- Home
- CNTA vs TRUP Comparison
CNTA vs TRUP Comparison
Compare CNTA & TRUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- TRUP
- Stock Information
- Founded
- CNTA 2020
- TRUP 2000
- Country
- CNTA United Kingdom
- TRUP United States
- Employees
- CNTA N/A
- TRUP N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- TRUP Medical Specialities
- Sector
- CNTA Health Care
- TRUP Health Care
- Exchange
- CNTA Nasdaq
- TRUP Nasdaq
- Market Cap
- CNTA 1.6B
- TRUP 1.9B
- IPO Year
- CNTA 2021
- TRUP 2014
- Fundamental
- Price
- CNTA $13.51
- TRUP $47.19
- Analyst Decision
- CNTA Strong Buy
- TRUP Buy
- Analyst Count
- CNTA 11
- TRUP 6
- Target Price
- CNTA $27.00
- TRUP $51.80
- AVG Volume (30 Days)
- CNTA 730.3K
- TRUP 579.4K
- Earning Date
- CNTA 05-14-2025
- TRUP 05-01-2025
- Dividend Yield
- CNTA N/A
- TRUP N/A
- EPS Growth
- CNTA N/A
- TRUP N/A
- EPS
- CNTA N/A
- TRUP N/A
- Revenue
- CNTA $15,000,000.00
- TRUP $1,321,538,000.00
- Revenue This Year
- CNTA N/A
- TRUP $10.99
- Revenue Next Year
- CNTA N/A
- TRUP $5.33
- P/E Ratio
- CNTA N/A
- TRUP N/A
- Revenue Growth
- CNTA 118.88
- TRUP 14.08
- 52 Week Low
- CNTA $7.90
- TRUP $25.90
- 52 Week High
- CNTA $19.09
- TRUP $57.90
- Technical
- Relative Strength Index (RSI)
- CNTA 56.37
- TRUP 64.78
- Support Level
- CNTA $12.11
- TRUP $42.71
- Resistance Level
- CNTA $13.23
- TRUP $48.87
- Average True Range (ATR)
- CNTA 0.73
- TRUP 1.56
- MACD
- CNTA 0.12
- TRUP 0.00
- Stochastic Oscillator
- CNTA 98.13
- TRUP 72.73
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About TRUP Trupanion Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.